https://www.selleckchem.com/pr....oducts/actinomycin-d
0 days for subjects treated with 30 Gy in less then 10 fractions (n = 7) vs 78.5 days for subjects treated with 30 Gy in ≥10 fractions (n = 24) (P less then .01) and 23.0 days for the triple-negative subtype vs 78.5 days for the other subtype (P less then .01) groups. Univariate analysis using the Cox regression model showed significant differences in median survival time after cancerous meningitis diagnosis between the group treated with 30 Gy in less then 10 fractions and the group treated in ≥10 fractions (hazard ratio [H
Like
Comment
Share
